©1996-2020. All
Rights Reserved. Online Journal of
Bioinformatics. You may not store these pages in any form except
for your own personal use. All other usage or distribution is illegal under
international copyright treaties. Permission
to use any of these pages in any other way besides the before mentioned must be
gained in writing from the publisher. This article is exclusively
copyrighted in its entirety to OJIM publications. This article may be copied
once but may not be, reproduced or re-transmitted without the express
permission of the editors. Linking: To link to this page or any pages linking
to this page you must link directly to this page only here rather than put up
your own page.
OJBtm
Online
Journal of Bioinformatics©
Established
1995
ISSN 1443-2250
Volume 20(1):32-42, 2019.
Molecular docking of
curcumin analogs with phospholipase A2.
Dileep KV, Tintu
G, Sadasivan, C*
Department
of Biotechnology and Microbiology, Kannur University, Thalassery
Campus, Palayad P O,
Kerala – 670661, India.
ABSTRACT
Dileep KV, Tintu
G, Sadasivan C., Molecular docking of curcumin analogs with phospholipase A2, Onl J Bioinform., 20(1):32-42, 2019. The enzyme phospholipase
A2 is responsible for the hydrolysis of membrane phospholipids that
release arachidonic acid, which serves as substrate for pro-inflammatory
mediators, such as prostaglandins and leukotrienes. Binding of the substrate to
PLA2 occurs through a well-formed hydrophobic channel and blocking
the hydrophobic channel is an effective way to inhibit PLA2.
Compounds inhibiting PLA2 have been implicated as potential
therapeutic agents in treatment of inflammation related diseases. Curcumin is a
well studied compound isolated from the plant Curcuma longa. We describe binding of 28
curcumin analogs to PLA2 by molecular modeling and docking and mode
of interactions of compounds with strong binding. We determined that natural and
synthetic analogs rosmarinic acid, tetrahydrocurcumin, dihydrocurucmin
and hexahydrocurcumin had higher binding energy than
curcumin. These findings may lead to better
understanding of PLA2 inhibition by curcumin analogs and improved
anti-inflammatory drugs.
Keywords : PLA2: curcumin analogs : Molecular docking, PLA2
FULL-TEXT (SUBSCRIBE OR
PURCHASE TITLE)